Arrowhead Pharmaceuticals, Inc. (FRA:HDP1)

Arrowhead Pharmaceuticals Ratios and Metrics

Market cap in millions EUR. Fiscal year is October - September.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jan 29, 2026	Sep 30, 2025	Sep 30, 2024	Sep 30, 2023	Sep 30, 2022	Sep 30, 2021
Market Capitalization	8,170	4,064	2,159	2,721	3,568	5,616
Market Cap Growth	256.88%	88.24%	-20.66%	-23.72%	-36.47%	49.72%
Enterprise Value	8,056	3,911	2,184	2,644	3,246	5,191
Last Close Price	58.36	28.97	17.46	25.31	33.60	52.20
PS Ratio	11.56	5.75	678.12	11.96	14.38	47.07
PB Ratio	19.04	9.47	12.60	10.03	8.36	15.92
P/TBV Ratio	20.88	10.39	13.61	11.03	9.05	16.47
P/FCF Ratio	61.10	30.40	-	-	-	44.06
P/OCF Ratio	53.39	26.56	-	-	-	37.99
EV/Sales Ratio	11.54	5.53	686.02	11.63	13.09	43.51
EV/EBITDA Ratio	68.96	37.52	-	-	-	-
EV/EBIT Ratio	97.32	46.65	-	-	-	-
EV/FCF Ratio	60.25	29.25	-	-	-	40.72
Debt / Equity Ratio	1.48	1.48	4.46	1.34	0.20	0.06
Debt / EBITDA Ratio	5.36	5.36	-	-	-	-
Debt / FCF Ratio	4.74	4.74	-	-	-	0.17
Asset Turnover	0.66	0.66	0.00	0.33	0.35	0.22
Quick Ratio	4.73	4.73	6.57	3.75	2.67	2.58
Current Ratio	4.86	4.86	6.74	3.95	2.92	2.63
Return on Equity (ROE)	8.67%	8.67%	-254.98%	-59.33%	-42.68%	-32.36%
Return on Assets (ROA)	4.87%	4.87%	-39.43%	-17.58%	-15.91%	-15.11%
Return on Invested Capital (ROIC)	17.11%	16.53%	-187.71%	-101.05%	-180.86%	-127.38%
Return on Capital Employed (ROCE)	8.30%	8.30%	-58.00%	-31.10%	-32.30%	-26.40%
Earnings Yield	-0.02%	-0.03%	-24.90%	-7.13%	-5.03%	-2.16%
FCF Yield	1.64%	3.29%	-25.10%	-11.48%	-5.40%	2.27%
Buyback Yield / Dilution	-11.67%	-11.67%	-12.21%	-1.26%	-1.62%	-3.00%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.